CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $62K of Crinetics Pharmaceuticals, Inc.
Sold$61,617
$19.73Price
3,123Shares
−2%Stake
What CRNX did after the filing
- The stock from Thu, Mar 3 open, $19.60
- +32.7%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Apr 14 close.
Traded Tue, Mar 1. Filed Wed, Mar 2, 4:00 PM ET, after the close. Returns use the Mar 3 open and the Apr 14 close. Not investment advice.